We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$2.21B
AUM Growth
+$110M
Cap. Flow
-$79.3M
Cap. Flow %
-3.59%
Top 10 Hldgs %
22.7%
Holding
3,121
New
66
Increased
341
Reduced
717
Closed
30

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$3.73M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$3.01M
3
COP icon
ConocoPhillips
COP
+$2.6M
4
NOW icon
ServiceNow
NOW
+$1.95M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$1.95M

Top Sells

Rank Stock Value
1
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$6.14M
2
MSFT icon
Microsoft
MSFT
+$4.3M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$3.96M
4
TER icon
Teradyne
TER
+$3.85M
5
ETSY icon
Etsy
ETSY
+$3.81M

Sector Composition

Rank Sector Weight
1 Technology 17.76%
2 Consumer Discretionary 10.46%
3 Healthcare 9.6%
4 Financials 9.53%
5 Industrials 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELA icon
3026
Envela
ELA
$419M
$3K ﹤0.01%
682
– –
ENB icon
3027
Enbridge
ENB
$112B
$3K ﹤0.01%
117
-771
-87% -$24.3K
EPM icon
3028
Evolution Petroleum
EPM
$134M
$3K ﹤0.01%
1,370
– –
FBT icon
3029
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.81B
$3K ﹤0.01%
25
– –
ING icon
3030
ING
ING
$102B
$3K ﹤0.01%
+562
New +$4.29K
NLY icon
3031
Annaly Capital Management
NLY
$17.4B
$3K ﹤0.01%
125
– –
IMDX
3032
Insight Molecular Diagnostics
IMDX
$147M
$3K ﹤0.01%
95
– –
PNRG icon
3033
PrimeEnergy Resources
PNRG
$323M
$3K ﹤0.01%
46
– –
SMLV icon
3034
State Street SPDR US Small Cap Low Volatility Index ETF
SMLV
$261M
$3K ﹤0.01%
40
– –
TARA icon
3035
Protara Therapeutics
TARA
$219M
$3K ﹤0.01%
178
– –
XGN icon
3036
Exagen
XGN
$160M
$3K ﹤0.01%
285
– –
ABTC
3037
American Bitcoin Corp
ABTC
$505M
– –
0
– –
STSA
3038
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$3K ﹤0.01%
812
– –
BIOR
3039
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$3K ﹤0.01%
+1
New +$2.26K
BXG
3040
DELISTED
Bluegreen Vacations Corporation Common Stock
BXG
$3K ﹤0.01%
637
– –
BLPH
3041
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$3K ﹤0.01%
304
– –
CHGA
3042
Change Agents Corporation Common Stock
CHGA
$3.02M
$2K ﹤0.01%
13
– –
AOA icon
3043
iShares Core 80/20 Aggressive Allocation ETF
AOA
$3.28B
$2K ﹤0.01%
43
– –
ARCC icon
3044
Ares Capital
ARCC
$14.3B
$2K ﹤0.01%
213
– –
ARL icon
3045
American Realty Investors
ARL
$243M
$2K ﹤0.01%
174
– –
AYTU icon
3046
AYTU BioPharma
AYTU
$25.3M
$2K ﹤0.01%
10
– –
CIX icon
3047
Comp X International
CIX
$386M
$2K ﹤0.01%
124
– –
IYM icon
3048
iShares US Basic Materials ETF
IYM
$1.02B
$2K ﹤0.01%
30
– –
NEXT icon
3049
NextDecade
NEXT
$1.8B
$2K ﹤0.01%
638
– –
NL icon
3050
NLI Holdings
NL
$329M
$2K ﹤0.01%
532
– –
120 121
122
123 124

Similar funds

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
PCM
Prana Capital Management Greenwich, Connecticut $3.29B AUM 2.24% 1-Year Est. Return
EWA
Exencial Wealth Advisors Oklahoma City, Oklahoma $3.22B AUM 20.17% 1-Year Est. Return
SYBT
Stock Yards Bank & Trust Louisville, Kentucky $3.21B AUM 22.76% 1-Year Est. Return
SM
SCGE Management Menlo Park, California $3.3B AUM 18.27% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
YCM
Yaupon Capital Management New York $3.2B AUM 46.52% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.2B AUM 41.22% 1-Year Est. Return

Ameritas Investment Partners's Q3 2020 Portfolio in Review

As of Q3 2020, Ameritas Investment Partners held 3,121 positions worth $2.21B, up 5.2% from $2.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Ameritas Investment Partners withdrew a net $79.3M in Q3 2020, closing 30 positions and reducing 717 holdings. Its most notable exit was Caesars Entertainment Corporation, an estimated $1.97M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Ameritas Investment Partners opened a new position in Jazz Pharmaceuticals worth $2.24M.

  • Ameritas Investment Partners's largest Q3 2020 buy was Jazz Pharmaceuticals: 15,701 shares worth $2.24M.
  • Ameritas Investment Partners added most to Invesco QQQ Trust in Q3 2020, an estimated $3.73M increase.
  • Ameritas Investment Partners's biggest Q3 2020 reduction was State Street SPDR S&P MIDCAP 400 ETF Trust, cutting an estimated $6.14M.
  • Ameritas Investment Partners fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $1.97M.
  • Ameritas Investment Partners's ten largest holdings make up 23% of its $2.21B portfolio in Q3 2020.
  • Ameritas Investment Partners opened 66 new positions and closed 30 in Q3 2020.
  • Ameritas Investment Partners's portfolio value rose 5.2% quarter-over-quarter to $2.21B.

Based on Ameritas Investment Partners's 13F filing for Q3 2020, filed 13 Nov 2020.